Covered recipient · General Payments record
COLIN J KUGELMANN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,724.22
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,752.96 | 4 |
| Food and Beverage | $322.83 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $1,752.96 | 4 |
| Averitas Pharma Inc. | $102.50 | 1 |
| Nevro Corp. | $62.46 | 2 |
| ABBVIE INC. | $28.29 | 1 |
| DEXCOM, INC. | $21.38 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.40 | 1 |
| Acerta Pharma LLC | $19.45 | 1 |
| Amgen Inc. | $19.23 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.42 | 1 |
| Lilly USA, LLC | $15.72 | 1 |
| GlaxoSmithKline, LLC. | $14.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.29 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107491089 | CMS |
| Amgen Inc. | $19.23 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117603427 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.45 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105683947 | CMS |
| Averitas Pharma Inc. | $102.50 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133463092 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.42 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117979524 | CMS |
| Dexcom, Inc. | $21.38 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153355344 | CMS |
| GlaxoSmithKline, LLC. | $14.98 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116453229 | CMS |
| Lilly USA, LLC | $15.72 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135592800 | CMS |
| Medtronic, Inc. | $1,032.92 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116938773 | CMS |
| Medtronic, Inc. | $640.94 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116938777 | CMS |
| Medtronic, Inc. | $34.25 | 05/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116938775 | CMS |
| Medtronic, Inc. | $44.85 | 05/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1116938779 | CMS |
| Nevro Corp. | $31.06 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130766142 | CMS |
| Nevro Corp. | $31.40 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130766140 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.40 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119116571 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.